The US Food and Drug Administration (FDA) classified this as a Class 1 recall, meaning the product posed a serious health ...

X4 Pharmaceuticals is laying off 30% of its staff and halting preclinical R&D as the immune system specialist channels its resources into recently approved rare disease drug mavorixafor.

An estimated 15 million Americans have food allergies, which result in 30,000 ED visits and 150–200 fatalities annually ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...